Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 455

1.

Surgical Management of Dysplasia and Cancer in Inflammatory Bowel Disease.

Ansell J, Grass F, Merchea A.

Surg Clin North Am. 2019 Dec;99(6):1111-1121. doi: 10.1016/j.suc.2019.08.006. Epub 2019 Sep 23. Review.

PMID:
31676051
2.

Risk factors for 90-day readmission and return to the operating room following abdominal operations for Crohn's disease.

Grass F, Ansell J, Petersen M, Mathis KL, Lightner AL.

Surgery. 2019 Dec;166(6):1068-1075. doi: 10.1016/j.surg.2019.08.006. Epub 2019 Sep 20.

PMID:
31548096
3.

Developments in understanding and applying prebiotics in research and practice-an ISAPP conference paper.

Scott KP, Grimaldi R, Cunningham M, Sarbini SR, Wijeyesekera A, Tang MLK, Lee JC, Yau YF, Ansell J, Theis S, Yang K, Menon R, Arfsten J, Manurung S, Gourineni V, Gibson GR.

J Appl Microbiol. 2019 Aug 25. doi: 10.1111/jam.14424. [Epub ahead of print] Review.

PMID:
31446668
4.

A systematic review and meta-analysis of supplemental education in patients treated with oral anticoagulation.

Paquette M, Witt DM, Holbrook A, Skov J, Ansell J, Schünemann HJ, Wiercioch W, Nieuwlaat R.

Blood Adv. 2019 May 28;3(10):1638-1646. doi: 10.1182/bloodadvances.2019000067. Review.

5.

The effect of 'Zesy002' kiwifruit (Actinidia chinensis var. chinensis) on gut health function: a randomised cross-over clinical trial.

Eady SL, Wallace AJ, Butts CA, Hedderley D, Drummond L, Ansell J, Gearry RB.

J Nutr Sci. 2019 May 3;8:e18. doi: 10.1017/jns.2019.14. eCollection 2019.

6.

Comparison of Patient-Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT - AF Registry.

Perino AC, Shrader P, Turakhia MP, Ansell JE, Gersh BJ, Fonarow GC, Go AS, Kaiser DW, Hylek EM, Kowey PR, Singer DE, Thomas L, Steinberg BA, Peterson ED, Piccini JP, Mahaffey KW.

J Am Heart Assoc. 2019 May 7;8(9):e011205. doi: 10.1161/JAHA.118.011205.

7.

Reversal of direct oral anticoagulants: Guidance from the Anticoagulation Forum.

Cuker A, Burnett A, Triller D, Crowther M, Ansell J, Van Cott EM, Wirth D, Kaatz S.

Am J Hematol. 2019 Jun;94(6):697-709. doi: 10.1002/ajh.25475. Epub 2019 Apr 16. Review.

PMID:
30916798
8.

Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation.

Madhavan M, Holmes DN, Piccini JP, Ansell JE, Fonarow GC, Hylek EM, Kowey PR, Mahaffey KW, Thomas L, Peterson ED, Chan P, Allen LA, Gersh BJ; ORBIT AF Investigators.

Am Heart J. 2019 May;211:77-89. doi: 10.1016/j.ahj.2019.01.005. Epub 2019 Jan 30.

PMID:
30901602
9.

Vitamin K for reversal of excessive vitamin K antagonist anticoagulation: a systematic review and meta-analysis.

Khatib R, Ludwikowska M, Witt DM, Ansell J, Clark NP, Holbrook A, Wiercioch W, Schünemann H, Nieuwlaat R.

Blood Adv. 2019 Mar 12;3(5):789-796. doi: 10.1182/bloodadvances.2018025163. Review.

10.

Mechanisms underlying effects of kiwifruit on intestinal function shown by MRI in healthy volunteers.

Wilkinson-Smith V, Dellschaft N, Ansell J, Hoad C, Marciani L, Gowland P, Spiller R.

Aliment Pharmacol Ther. 2019 Mar;49(6):759-768. doi: 10.1111/apt.15127. Epub 2019 Jan 31.

11.

Comparison of recovery and outcome after left and right colectomy.

Grass F, Lovely JK, Crippa J, Ansell J, Hübner M, Mathis KL, Larson DW.

Colorectal Dis. 2019 Apr;21(4):481-486. doi: 10.1111/codi.14543. Epub 2019 Jan 18.

PMID:
30585680
12.

A Novel Whole Blood Point-of-Care Coagulometer to Measure the Effect of Direct Oral Anticoagulants and Heparins.

Ansell J, Zappe S, Jiang X, Chen L, Steiner S, Laulicht B, Bakhru S.

Semin Thromb Hemost. 2019 Apr;45(3):259-263. doi: 10.1055/s-0038-1676317. Epub 2018 Dec 19.

PMID:
30566966
13.

American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy.

Witt DM, Nieuwlaat R, Clark NP, Ansell J, Holbrook A, Skov J, Shehab N, Mock J, Myers T, Dentali F, Crowther MA, Agarwal A, Bhatt M, Khatib R, Riva JJ, Zhang Y, Guyatt G.

Blood Adv. 2018 Nov 27;2(22):3257-3291. doi: 10.1182/bloodadvances.2018024893.

14.

Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT-AF.

Washam JB, Holmes DN, Thomas LE, Pokorney SD, Hylek EM, Fonarow GC, Mahaffey KW, Gersh BJ, Kowey PR, Ansell JE, Go AS, Reiffel JA, Freeman JV, Singer DE, Naccarelli G, Blanco R, Peterson ED, Piccini JP.

J Am Heart Assoc. 2018 Sep 18;7(18):e008928. doi: 10.1161/JAHA.118.008928.

15.

Impact of Storage Lesion on Post-transfusion Rise in Hemoglobin.

Sardar M, Shaikh N, Ansell J, Jacob A, Yada S, Kelly DB, Doraiswamy M, Khan WJ, Anwer F, Eng MH.

Cureus. 2018 Jul 9;10(7):e2952. doi: 10.7759/cureus.2952.

16.

Incremental prognostic value of renal function for stroke prediction in atrial fibrillation.

O'Brien EC, Holmes DN, Thomas L, Singer DE, Fonarow GC, Mahaffey KW, Kowey PR, Hylek EM, Pokorney SD, Ansell JE, Pencina MJ, Peterson ED, Piccini JP; ORBIT-AF Patients & Investigators.

Int J Cardiol. 2019 Jan 1;274:152-157. doi: 10.1016/j.ijcard.2018.07.113. Epub 2018 Jul 25.

PMID:
30144994
17.

Defining Minimum Necessary Anticoagulation-Related Communication at Discharge: Consensus of the Care Transitions Task Force of the New York State Anticoagulation Coalition.

Triller D, Myrka A, Gassler J, Rudd K, Meek P, Kouides P, Burnett AE, Spyropoulos AC, Ansell J.

Jt Comm J Qual Patient Saf. 2018 Nov;44(11):630-640. doi: 10.1016/j.jcjq.2018.04.015. Epub 2018 Jul 24.

PMID:
30064950
18.

Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.

Jackson LR 2nd, Kim S, Shrader P, Blanco R, Thomas L, Ezekowitz MD, Ansell J, Fonarow GC, Gersh BJ, Go AS, Kowey PR, Mahaffey KW, Hylek EM, Peterson ED, Piccini JP Sr.

J Thromb Thrombolysis. 2018 Nov;46(4):435-439. doi: 10.1007/s11239-018-1715-1.

19.

Therapeutic Strategies Following Major, Clinically Relevant Nonmajor, and Nuisance Bleeding in Atrial Fibrillation: Findings From ORBIT-AF.

O'Brien EC, Holmes DN, Thomas L, Fonarow GC, Kowey PR, Ansell JE, Mahaffey KW, Gersh BJ, Peterson ED, Piccini JP, Hylek EM.

J Am Heart Assoc. 2018 Jun 9;7(12). pii: e006391. doi: 10.1161/JAHA.117.006391.

20.

A Retrospective and Prospective Study to Develop a Pre-operative Difficulty Score for Laparoscopic Cholecystectomy.

Ibrahim Y, Radwan RW, Abdullah AAN, Sherif M, Khalid U, Ansell J, Rasheed A.

J Gastrointest Surg. 2019 Apr;23(4):690-695. doi: 10.1007/s11605-018-3821-y. Epub 2018 May 29.

PMID:
29845574
21.

Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients With Atrial Fibrillation.

O'Brien EC, Holmes DN, Thomas LE, Fonarow GC, Allen LA, Gersh BJ, Kowey PR, Singer DE, Ezekowitz MD, Naccarelli GV, Ansell JE, Chan PS, Mahaffey KW, Go AS, Freeman JV, Reiffel JA, Peterson ED, Piccini JP, Hylek EM.

Circulation. 2018 Aug 28;138(9):889-897. doi: 10.1161/CIRCULATIONAHA.117.031354.

PMID:
29678813
22.

The nutritional and health attributes of kiwifruit: a review.

Richardson DP, Ansell J, Drummond LN.

Eur J Nutr. 2018 Dec;57(8):2659-2676. doi: 10.1007/s00394-018-1627-z. Epub 2018 Feb 22. Review.

23.

Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II).

Steinberg BA, Shrader P, Pieper K, Thomas L, Allen LA, Ansell J, Chan PS, Ezekowitz MD, Fonarow GC, Freeman JV, Gersh BJ, Kowey PR, Mahaffey KW, Naccarelli GV, Reiffel JA, Singer DE, Peterson ED, Piccini JP; Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT‐AF) II Investigators.

J Am Heart Assoc. 2018 Feb 16;7(4). pii: e007633. doi: 10.1161/JAHA.117.007633.

24.

Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT-AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation).

Thomas KL, Jackson LR 2nd, Shrader P, Ansell J, Fonarow GC, Gersh B, Kowey PR, Mahaffey KW, Singer DE, Thomas L, Piccini JP, Peterson ED.

J Am Heart Assoc. 2017 Dec 22;6(12). pii: e006475. doi: 10.1161/JAHA.117.006475.

25.

International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries.

Steinberg BA, Gao H, Shrader P, Pieper K, Thomas L, Camm AJ, Ezekowitz MD, Fonarow GC, Gersh BJ, Goldhaber S, Haas S, Hacke W, Kowey PR, Ansell J, Mahaffey KW, Naccarelli G, Reiffel JA, Turpie A, Verheugt F, Piccini JP, Kakkar A, Peterson ED, Fox KAA; GARFIELD-AF; ORBIT-AF Investigators.

Am Heart J. 2017 Dec;194:132-140. doi: 10.1016/j.ahj.2017.08.011. Epub 2017 Aug 24.

26.

Executive function assessment in New Zealand 2-year olds born at risk of neonatal hypoglycemia.

Ansell JM, Wouldes TA, Harding JE; CHYLD Study group.

PLoS One. 2017 Nov 22;12(11):e0188158. doi: 10.1371/journal.pone.0188158. eCollection 2017.

27.

Consumption of kiwifruit capsules increases Faecalibacterium prausnitzii abundance in functionally constipated individuals: a randomised controlled human trial.

Blatchford P, Stoklosinski H, Eady S, Wallace A, Butts C, Gearry R, Gibson G, Ansell J.

J Nutr Sci. 2017 Oct 12;6:e52. doi: 10.1017/jns.2017.52. eCollection 2017.

28.

Treatment of Atrial Fibrillation and Concordance With the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines: Findings From ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation).

Barnett AS, Kim S, Fonarow GC, Thomas LE, Reiffel JA, Allen LA, Freeman JV, Naccarelli G, Mahaffey KW, Go AS, Kowey PR, Ansell JE, Gersh BJ, Hylek EM, Peterson ED, Piccini JP.

Circ Arrhythm Electrophysiol. 2017 Nov;10(11). pii: e005051. doi: 10.1161/CIRCEP.117.005051.

PMID:
29141842
29.

A systematic review of Clostridium difficile infection following reversal of ileostomy.

Harries RL, Ansell J, Codd RJ, Williams GL.

Colorectal Dis. 2017 Oct;19(10):881-887. doi: 10.1111/codi.13873. Review.

PMID:
28872758
30.

Global motion perception is associated with motor function in 2-year-old children.

Thompson B, McKinlay CJD, Chakraborty A, Anstice NS, Jacobs RJ, Paudel N, Yu TY, Ansell JM, Wouldes TA, Harding JE; CHYLD Study Team.

Neurosci Lett. 2017 Sep 29;658:177-181. doi: 10.1016/j.neulet.2017.08.062. Epub 2017 Aug 31.

31.

Management and outcomes of patients with atrial fibrillation and a history of cancer: the ORBIT-AF registry.

Melloni C, Shrader P, Carver J, Piccini JP, Thomas L, Fonarow GC, Ansell J, Gersh B, Go AS, Hylek E, Herling IM, Mahaffey KW, Yu AF, Peterson ED, Kowey PR; ORBIT-AF Steering Committee.

Eur Heart J Qual Care Clin Outcomes. 2017 Jul 1;3(3):192-197. doi: 10.1093/ehjqcco/qcx004.

PMID:
28838088
32.

"Birds of a Feather" Fail Together: Exploring the Nature of Dependency in SME Defaults.

Calabrese R, Andreeva G, Ansell J.

Risk Anal. 2019 Jan;39(1):71-84. doi: 10.1111/risa.12862. Epub 2017 Aug 11.

PMID:
28799646
33.

Disease understanding in patients newly diagnosed with atrial fibrillation.

Kaufman BG, Kim S, Pieper K, Allen LA, Gersh BJ, Naccarelli GV, Ezekowitz MD, Fonarow GC, Mahaffey KW, Singer DE, Chan PS, Freeman JV, Ansell J, Kowey PR, Rieffel JA, Piccini J, Peterson E, O'Brien EC.

Heart. 2018 Mar;104(6):494-501. doi: 10.1136/heartjnl-2017-311800. Epub 2017 Aug 8.

34.

Stroke Prevention in Atrial Fibrillation in the Very Elderly: Anticoagulant Therapy Is No Longer a Sin.

Ansell J.

J Am Heart Assoc. 2017 Jul 23;6(7). pii: e006864. doi: 10.1161/JAHA.117.006864. No abstract available.

35.

A Pilot Randomized Cross-Over Trial to Examine the Effect of Kiwifruit on Satiety and Measures of Gastric Comfort in Healthy Adult Males.

Wallace A, Eady S, Drummond L, Hedderley D, Ansell J, Gearry R.

Nutrients. 2017 Jun 22;9(7). pii: E639. doi: 10.3390/nu9070639.

36.

Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).

Steinberg BA, Shrader P, Thomas L, Ansell J, Fonarow GC, Gersh BJ, Hylek E, Kowey PR, Mahaffey KW, O'Brien EC, Singer DE, Peterson ED, Piccini JP; Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigators and Patients.

Am Heart J. 2017 Jul;189:40-47. doi: 10.1016/j.ahj.2017.03.024. Epub 2017 Apr 4.

37.

Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation.

Black-Maier E, Kim S, Steinberg BA, Fonarow GC, Freeman JV, Kowey PR, Ansell J, Gersh BJ, Mahaffey KW, Naccarelli G, Hylek EM, Go AS, Peterson ED, Piccini JP; Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigators.

Clin Cardiol. 2017 Sep;40(9):746-751. doi: 10.1002/clc.22726. Epub 2017 May 19.

38.

Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II]).

Steinberg BA, Simon DN, Thomas L, Ansell J, Fonarow GC, Gersh BJ, Kowey PR, Mahaffey KW, Peterson ED, Piccini JP; Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigators and Patients.

Am J Cardiol. 2017 May 15;119(10):1590-1595. doi: 10.1016/j.amjcard.2017.02.015. Epub 2017 Mar 28.

39.

Economic Analysis of Apixaban Therapy for Patients With Atrial Fibrillation From a US Perspective: Results From the ARISTOTLE Randomized Clinical Trial.

Cowper PA, Sheng S, Lopes RD, Anstrom KJ, Stafford JA, Davidson-Ray L, Al-Khatib SM, Ansell J, Dorian P, Husted S, McMurray JJV, Steg PG, Alexander JH, Wallentin L, Granger CB, Mark DB.

JAMA Cardiol. 2017 May 1;2(5):525-534. doi: 10.1001/jamacardio.2017.0065.

40.

Thrombophilic Evaluation in Patients with Acute Pulmonary Embolism.

Stevens SM, Ansell JE.

Semin Respir Crit Care Med. 2017 Feb;38(1):107-120. doi: 10.1055/s-0036-1597564. Epub 2017 Feb 16. Review.

PMID:
28208204
41.

Consumption of antimicrobial manuka honey does not significantly perturb the microbiota in the hind gut of mice.

Rosendale D, Butts CA, de Guzman CE, Maddox IS, Martell S, McIntyre L, Skinner MA, Dinnan H, Ansell J.

PeerJ. 2016 Dec 20;4:e2787. doi: 10.7717/peerj.2787. eCollection 2016.

42.

Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes: The ORBIT-AF II Registry.

Steinberg BA, Shrader P, Thomas L, Ansell J, Fonarow GC, Gersh BJ, Kowey PR, Mahaffey KW, Naccarelli G, Reiffel J, Singer DE, Peterson ED, Piccini JP; ORBIT-AF Investigators and Patients.

J Am Coll Cardiol. 2016 Dec 20;68(24):2597-2604. doi: 10.1016/j.jacc.2016.09.966.

43.

Absence of Oral Anticoagulation and Subsequent Outcomes Among Outpatients with Atrial Fibrillation.

Hess PL, Kim S, Fonarow GC, Thomas L, Singer DE, Freeman JV, Gersh BJ, Ansell J, Kowey PR, Mahaffey KW, Chan PS, Steinberg BA, Peterson ED, Piccini JP; Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Patients and Investigators.

Am J Med. 2017 Apr;130(4):449-456. doi: 10.1016/j.amjmed.2016.11.001. Epub 2016 Nov 23.

44.

Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxaban.

Ansell JE, Bakhru SH, Laulicht BE, Steiner SS, Grosso MA, Brown K, Dishy V, Lanz HJ, Mercuri MF, Noveck RJ, Costin JC.

Thromb Haemost. 2017 Jan 26;117(2):238-245. doi: 10.1160/TH16-03-0224. Epub 2016 Nov 17.

45.

How well does physician risk assessment predict stroke and bleeding in atrial fibrillation? Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

Steinberg BA, Shrader P, Kim S, Thomas L, Fonarow GC, Ansell J, Kowey PR, Singer DE, Gersh BJ, Mahaffey KW, Peterson ED, Piccini JP; ORBIT-AF Investigators and Patients.

Am Heart J. 2016 Nov;181:145-152. doi: 10.1016/j.ahj.2016.07.026. Epub 2016 Aug 27.

46.

Influence of Kidney Function Estimation Methods on Eligibility for Edoxaban Population Impact of the US Food and Drug Administration's Approach for Its Product Labeling.

Pokorney SD, Shrader P, Thomas L, Fonarow GC, Kowey PR, Singer DE, Ansell J, Gersh BJ, Mahaffey KW, Hylek EM, Go AS, Piccini JP, Peterson ED; Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigators.

Circulation. 2016 Oct 11;134(15):1122-1124. No abstract available.

PMID:
27753615
47.
48.

Reversal Agents for the Direct Oral Anticoagulants.

Ansell JE.

Hematol Oncol Clin North Am. 2016 Oct;30(5):1085-98. doi: 10.1016/j.hoc.2016.05.006. Review.

PMID:
27637309
49.

Hughes Abdominal Repair Trial (HART) - Abdominal wall closure techniques to reduce the incidence of incisional hernias: study protocol for a randomised controlled trial.

Cornish J, Harries RL, Bosanquet D, Rees B, Ansell J, Frewer N, Dhruva Rao PK, Parry C, Ellis-Owen R, Phillips SM, Morris C, Horwood J, Davies ML, Davies MM, Hargest R, Davies Z, Hilton J, Harris D, Ben-Sassi A, Rajagopal R, Hanratty D, Islam S, Watkins A, Bashir N, Jones S, Russell IR, Torkington J; HART Trial Management Group.

Trials. 2016 Sep 15;17(1):454. doi: 10.1186/s13063-016-1573-0.

50.

Ciraparantag safely and completely reverses the anticoagulant effects of low molecular weight heparin.

Ansell JE, Laulicht BE, Bakhru SH, Hoffman M, Steiner SS, Costin JC.

Thromb Res. 2016 Oct;146:113-118. doi: 10.1016/j.thromres.2016.07.008. Epub 2016 Jul 18.

PMID:
27470323

Supplemental Content

Loading ...
Support Center